Novartis wins FDA OK for radiopharmaceutical drug, cashing in on Endocyte deal
Dive Brief:
Novartis has won Food and Drug Administration approval to sell a radiopharmaceutical designed to treat a form of advanced prostate cancer in a key step...
Continue Reading →
